Penn Medicine, Intel collaborate on AI to identify brain tumors

Intel Labs is teaming up with the University of Pennsylvania's Perelman School of Medicine to develop artificial intelligence models that identify brain tumors using federated learning, a technique that protects patients' privacy.

To create an AI model that detects brain tumors early, researchers need extensive amounts of relevant data. Federated learning algorithms are designed to preserve the privacy of this  essential data while the researchers collaborate.  

Intel and Penn Medicine’s work is funded by the National Institutes of Health's Informatics Technology for Cancer Research program via a three-year, $1.2 million grant. They will be collaborating with 29 domestic and international research institutions on the project.

Read the full news release here.

More articles on artificial intelligence:
Workers who lost their job due to the pandemic may be replaced by automation during recovery, researchers say
AI spots potential COVID-19 treatment drug within two days
AI can categorize lung nodules' cancer risk, study suggests

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Content

Featured Webinars

Featured Whitepapers